CHI3L1 and asthma: In our cohort, comprising healthy controls and patients with AA and NA, we confirmed a significant decrease in CHI3L1 gene expression in PBMCs from asthma patients compared to controls (Figure 2A), consistent with prior findings [22,23,24,25].